|
Phần 2: Một số ấn bản mới nhất về nghiên cứu kháng thuốc sốt rét trên thế giới (Tháng 1_2013)
1. Drug-Resistant Malaria: The Era of ACT. Lin JT, Juliano JJ, Wongsrichanalai C. Curr Infect Dis Rep. 2010 May;12(3):165-73. doi: 10.1007/s11908-010-0099-y. PMID: 21308525 [PubMed] 2. [Combined antimalarial therapy using artemisinin]. Majori G. Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian. PMID:15305693 [PubMed - indexed for MEDLINE] 3. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. Barnes KI, White NJ. Acta Trop. 2005 Jun;94(3):230-40. Review. PMID: 15878154 [PubMed - indexed for MEDLINE] 4. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Mutabingwa TK. Acta Trop. 2005 Sep;95(3):305-15. Review. PMID: 16098946 [PubMed - indexed for MEDLINE] 5. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Bosman A, Mendis KN. Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):193-7. Review. PMID: 18165492 [PubMed - indexed for MEDLINE] 6. How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance. Hastings I. Trends Parasitol. 2011 Feb;27(2):67-72. doi: 10.1016/j.pt.2010.09.005. PMID: 20971040 [PubMed - indexed for MEDLINE] 7. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009. Thanh NV, Toan TQ, Cowman AF, Casey GJ, Phuc BQ, Tien NT, Hung NM, Biggs BA. Malar J. 2010 Jun 24;9:181. doi: 10.1186/1475-2875-9-181. PMID: 20573274 [PubMed - indexed for MEDLINE] 8. Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review. Olliaro PL, Taylor WR. J Postgrad Med. 2004 Jan-Mar;50(1):40-4. Review. PMID: 15047998 [PubMed - indexed for MEDLINE] 9. Artemisinin-based combination therapies and their introduction in Japan. Kano S. J Infect Chemother. 2010 Dec;16(6):375-82. doi: 10.1007/s10156-010-0077-1. Epub 2010 Jun 10. Review. PMID: 20535521 [PubMed - indexed for MEDLINE] 10. Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies. Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ. Malar J. 2008 Nov 2;7:229. doi: 10.1186/1475-2875-7-229. PMID: 18976503 [PubMed - indexed for MEDLINE] 11.Artemisinin-based combination therapy for treating uncomplicated malaria. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007483. doi: 10.1002/14651858.CD007483.pub2. Review. PMID:19588433 [PubMed - indexed for MEDLINE] 12. [Subsidized artemisinin based combination treatments for Africa]. Fandeur T, Abani M. Med Mal Infect. 2010 Nov;40(11):611-6. doi: 10.1016/j.medmal.2010.07.002. Epub 2010 Nov 3. Review. French. PMID: 21051164 [PubMed - indexed for MEDLINE] 13. Antimalarial compounds: from bench to bedside. Olliaro PL, Taylor WR. J Exp Biol. 2003 Nov;206(Pt 21):3753-9. Review. PMID: 14506210 [PubMed - indexed for MEDLINE] 14. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Eastman RT, Fidock DA. Nat Rev Microbiol. 2009 Dec;7(12):864-74. doi: 10.1038/nrmicro2239. Epub 2009 Nov 2. Review. PMID: 19881520 [PubMed - indexed for MEDLINE] 15. Advances in the treatment of malaria. Castelli F, Tomasoni LR, Matteelli A. Mediterr J Hematol Infect Dis. 2012;4(1):e2012064. doi: 10.4084/MJHID.2012.064. Epub 2012 Oct 3. PMID: 23170193 [PubMed] 16. Artemisinin derivatives and malaria: useful, in combination with other antimalarials. [No authors listed] Prescrire Int. 2008 Aug;17(96):162-8. PMID: 19492494 [PubMed - indexed for MEDLINE] 17. Discovery, mechanisms of action and combination therapy of artemisinin. Cui L, Su XZ. Expert Rev Anti Infect Ther. 2009 Oct;7(8):999-1013. doi: 10.1586/eri.09.68. Review. PMID: 19803708 [PubMed - indexed for MEDLINE] 18. Monitoring and deterring drug-resistant malaria in the era of combination therapy. Laufer MK, Djimdé AA, Plowe CV. Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):160-9. Review. PMID:18165489 [PubMed - indexed for MEDLINE] 19.Emerging drug--resistance and guidelines for treatment of malaria. Khan MA, Smego RA Jr, Razi ST, Beg MA. J Coll Physicians Surg Pak. 2004 May;14(5):319-24. Review. PMID:15225468 [PubMed - indexed for MEDLINE] 20.Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC. PLoS Med. 2008 Nov 25;5(11):e226; discussion e226. doi: 10.1371/journal.pmed.0050226. PMID:19067479 [PubMed - indexed for MEDLINE] 21. Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000. Ogbonna A, Uneke CJ. Trans R Soc Trop Med Hyg. 2008 Jul;102(7):621-7. doi: 10.1016/j.trstmh.2008.03.024. Epub 2008 May 21. Review. PMID:18499204 [PubMed - indexed for MEDLINE] 22.Artemisinin derivatives for treating uncomplicated malaria. McIntosh HM, Olliaro P. Cochrane Database Syst Rev. 2000;(2):CD000256. Review. PMID:10796519 [PubMed - indexed for MEDLINE] 23. Qinghaosu (artemisinin): the price of success. White NJ. Science. 2008 Apr 18;320(5874):330-4. doi: 10.1126/science.1155165. Review. PMID:18420924 [PubMed - indexed for MEDLINE] 24.A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire. Toure OA, Penali LK, Yapi JD, Ako BA, Toure W, Djerea K, Gomez GO, Makaila O. Malar J. 2009 Jul 3;8:148. doi: 10.1186/1475-2875-8-148. PMID:19575797 [PubMed - indexed for MEDLINE] 25.Artemisinin-based combination therapies for uncomplicated malaria. Davis TM, Karunajeewa HA, Ilett KF. Med J Aust. 2005 Feb 21;182(4):181-5. Review. PMID:15720175 [PubMed - indexed for MEDLINE] 26.Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Breman JG, Alilio MS, Mills A. Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):1-15. Review. PMID:15331814 [PubMed - indexed for MEDLINE] 27.[Combination therapy as a strategy to prevent antimalarial drug resistance]. Orjuela P, González I, Osorio L. Biomedica. 2004 Dec;24(4):423-37. Review. Spanish. PMID:15678806 [PubMed - indexed for MEDLINE] 28.Drug resistant falciparum malaria and the use of artesunate-based combinations: focus on clinical trials sponsored by TDR. Taylor WR, Rigal J, Olliaro PL. J Vector Borne Dis. 2003 Sep-Dec;40(3-4):65-72. Review. PMID:15119074 [PubMed - indexed for MEDLINE] 29.Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G. PLoS Med. 2005 Jul;2(7):e190. Epub 2005 Jul 26. PMID: 16033307[PubMed - indexed for MEDLINE] 30. In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes. Ekland EH, Fidock DA. Int J Parasitol. 2008 Jun;38(7):743-7. doi: 10.1016/j.ijpara.2008.03.004. Epub 2008 Apr 1. PMID: 18406409 [PubMed - indexed for MEDLINE] 31. Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy? Yeka A, Achan J, D'Alessandro U, Talisuna AO. Lancet Infect Dis. 2009 Jul;9(7):448-52. doi: 10.1016/S1473-3099(09)70109-4. Review. PMID: 19555904 [PubMed - indexed for MEDLINE] 32. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, Day NP, White NJ, White LJ. Malar J. 2009 Feb 20;8:31. doi: 10.1186/1475-2875-8-31. PMID: 19228438 [PubMed - indexed for MEDLINE] 33. Artemisinin-based combinations. Ashley EA, White NJ. Curr Opin Infect Dis. 2005 Dec;18(6):531-6. Review. PMID: 16258328 [PubMed - indexed for MEDLINE] 34. Chemotherapy of malaria. Ponnampalam JT. Ann Acad Med Singapore. 1981 Jan;10(1):99-106. PMID:7025744 [PubMed - indexed for MEDLINE] 35. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon. Whegang SY, Tahar R, Foumane VN, Soula G, Gwét H, Thalabard JC, Basco LK. Malar J. 2010 Feb 19;9:56. doi: 10.1186/1475-2875-9-56. PMID: 20170477 [PubMed - indexed for MEDLINE] 36. Monitoring antimalarial drug efficacy: current challenges. Laufer MK. Curr Infect Dis Rep. 2009 Jan;11(1):59-65. PMID: 19094826[PubMed] 37. Antimalarial drugs: modes of action and mechanisms of parasite resistance. Müller IB, Hyde JE. Future Microbiol. 2010 Dec;5(12):1857-73. doi: 10.2217/fmb.10.136. Review. PMID: 21155666 [PubMed - indexed for MEDLINE] 38. Epidemiology of drug-resistant malaria. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Lancet Infect Dis. 2002 Apr;2(4):209-18. Review. PMID: 11937421 [PubMed - indexed for MEDLINE] 39. Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Yeung S, Van Damme W, Socheat D, White NJ, Mills A. Malar J. 2008 May 29;7:96. doi: 10.1186/1475-2875-7-96. PMID: 18510724 [PubMed - indexed for MEDLINE] 40. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong TH, Tran TT, Stepniewska K, White NJ, Farrar J. Lancet. 2004 Jan 3;363(9402):18-22. PMID: 14723988 [PubMed - indexed for MEDLINE] Farooq U, Mahajan RC. J Vector Borne Dis. 2004 Sep-Dec;41(3-4):45-53. Review. PMID: 15672556 [PubMed - indexed for MEDLINE] 42.Clinical pharmacology of artemisinin-based combination therapies. German PI, Aweeka FT. Clin Pharmacokinet. 2008;47(2):91-102. Review. Erratum in: Clin Pharmacokinet. 2008;47(3):152. PMID: 18193915 [PubMed - indexed for MEDLINE] 43.Drug resistance among malaria and other parasites. Barat LM, Bloland PB. Infect Dis Clin North Am. 1997 Dec;11(4):969-87. Review. PMID: 9421710 [PubMed - indexed for MEDLINE] 44.Novel rational drug design strategies with potential to revolutionize malaria chemotherapy. Muregi FW, Kirira PG, Ishih A. Curr Med Chem. 2011;18(1):113-43. Review. PMID: 21110811 [PubMed - indexed for MEDLINE] 45.The detection and treatment of Plasmodium falciparum malaria: time for change. Nosten F, Ashley E. J Postgrad Med. 2004 Jan-Mar;50(1):35-9. PMID: 15047997 [PubMed - indexed for MEDLINE] 46.Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in south-west Nigeria: caution in the use of artemisinin combination therapy. Gbotosho GO, Happi CT, Ganiyu A, Ogundahunsi OA, Sowunmi A, Oduola AM. Malar J. 2009 Dec 30;8:313. doi: 10.1186/1475-2875-8-313. PMID: 20042098 [PubMed - indexed for MEDLINE] 47.Artemisinin-based combination treatment of falciparum malaria. Nosten F, White NJ. Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):181-92. Review. PMID:18165491 [PubMed - indexed for MEDLINE] 48.Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré. Bonnet M, Roper C, Félix M, Coulibaly L, Kankolongo GM, Guthmann JP. Malar J. 2007 May 3;6:54. PMID: 17477865 [PubMed - indexed for MEDLINE] 49.Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. Mugittu K, Genton B, Mshinda H, Beck HP. Malar J. 2006 Dec 19;5:126. PMID: 17177997 [PubMed - indexed for MEDLINE] 50.Chemotherapy and prevention of drug-resistant malaria. Kain KC. Wilderness Environ Med. 1995 Aug;6(3):307-24. Review. PMID: 11990096 [PubMed - indexed for MEDLINE] 51.The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen. Al-Shamahy H, Al-Harazy AH, Harmal NS, Al-Kabsi AM. Ann Saudi Med. 2007 Nov-Dec;27(6):432-6. PMID: 18059124 [PubMed - indexed for MEDLINE] 52.A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa. Coleman PG, Morel C, Shillcutt S, Goodman C, Mills AJ. Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):196-204. PMID: 15331838 [PubMed - indexed for MEDLINE] 53.Current status and progresses made in malaria chemotherapy. Liñares GE, Rodriguez JB. Curr Med Chem. 2007;14(3):289-314. Review. PMID: 17305534 [PubMed - indexed for MEDLINE] 54. Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin. Min-Oo G, Fortin A, Poulin JF, Gros P. Antimicrob Agents Chemother. 2010 Aug;54(8):3262-70. doi: 10.1128/AAC.01719-09. Epub 2010 May 17. PMID: 20479197 [PubMed - indexed for MEDLINE] 55. Simple field assays to check quality of current artemisinin-based antimalarial combination formulations. Ioset JR, Kaur H. PLoS one. 2009 Sep 30;4(9):e7270. doi: 10.1371/journal.pone.0007270. PMID: 19789707 [PubMed - indexed for MEDLINE] 56.A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Hutagalung R, Paiphun L, Ashley EA, McGready R, Brockman A, Thwai KL, Singhasivanon P, Jelinek T, White NJ, Nosten FH. Malar J. 2005 Sep 22;4:46. PMID: 16179089 [PubMed - indexed for MEDLINE] 57.The development of artemisinin resistance in malaria: reasons and solutions. Chrubasik C, Jacobson RL. Phytother Res. 2010 Jul;24(7):1104-6. doi: 10.1002/ptr.3133. PMID: 20578122 [PubMed - indexed for MEDLINE] 58.Advances in global biotechnology and local resources to treat malaria. Campagna AM, Patnaik MM. Minn Med. 2009 Feb;92(2):44-5. PMID:19331290 [PubMed - indexed for MEDLINE] 59.Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ. Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):179-86. Review. PMID: 15331836 [PubMed - indexed for MEDLINE] 60.[Treatment of pediatric malaria in Africa: act at issue]. Faucher JF, Missinou MA, Brasseur P. Med Trop (Mars). 2006 Jun;66(3):292-4. Review. French. PMID: 16924825 [PubMed - indexed for MEDLINE] 61.Management of Plasmodium falciparum malaria. Phillips RE. Med J Aust. 1984 Oct 13;141(8):511-7. PMID: 6482799 [PubMed - indexed for MEDLINE] 62.Phytochemical licochalcone A enhances antimalarial activity of artemisinin in vitro. Mishra LC, Bhattacharya A, Bhasin VK. Acta Trop. 2009 Mar;109(3):194-8. doi: 10.1016/j.actatropica.2008.11.006. Epub 2008 Nov 20. PMID: 19063856 [PubMed - indexed for MEDLINE] 63.Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ. Malar J. 2008 Jul 9;7:125. doi: 10.1186/1475-2875-7-125. PMID: 18613962 [PubMed - indexed for MEDLINE] 64.Drug-resistant malaria--occurrence, control, and surveillance. Wernsdorfer WH, Kouznetsov RL. Bull World Health Organ. 1980;58(3):341-52. PMID: 6998589 [PubMed - indexed for MEDLINE] 65.Antiplasmodial interactions between artemisinin and triclosan or ketoconazole combinations against blood stages of Plasmodium falciparum in vitro. Mishra LC, Bhattacharya A, Bhasin VK. Am J Trop Med Hyg. 2007 Mar;76(3):497-501. PMID: 17360874 [PubMed - indexed for MEDLINE] 66.Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S. Lancet. 2004 Jul 31-Aug 6;364(9432):438-47. PMID:15288742 [PubMed - indexed for MEDLINE] 67.Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria. Congpuong K, Bualombai P, Banmairuroi V, Na-Bangchang K. Malar J. 2010 Feb 4;9:43. doi: 10.1186/1475-2875-9-43. PMID:20132537 [PubMed - indexed for MEDLINE] 68.Quinolines and artemisinin: chemistry, biology and history. Bray PG, Ward SA, O'Neill PM. Curr Top Microbiol Immunol. 2005;295:3-38. Review. PMID: 16265885 [PubMed - indexed for MEDLINE] 69.Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Wongsrichanalai C, Sirichaisinthop J, Karwacki JJ, Congpuong K, Miller RS, Pang L, Thimasarn K. Southeast Asian J Trop Med Public Health. 2001 Mar;32(1):41-9. Review. PMID:11485094 [PubMed - indexed for MEDLINE] 70.[An imported case of falciparum malaria successfully treated with Artemether-Lumefantrine in Japan]. Ishizaki A, Kikuchi Y, Hatabu T, Kano S, Yasuoka A, Oka S. Kansenshogaku Zasshi. 2003 Jan;77(1):34-7. Japanese. PMID: 12638260 [PubMed - indexed for MEDLINE] 71.A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. Nair S, Williams JT, Brockman A, Paiphun L, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Hien TT, White NJ, Nosten F, Anderson TJ. Mol Biol Evol. 2003 Sep;20(9):1526-36. Epub 2003 Jun 27. PMID: 12832643 [PubMed - indexed for MEDLINE] 72.A global subsidy for antimalarial drugs. Gelband H, Seiter A. Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):219-21. Review. PMID:18165495 [PubMed - indexed for MEDLINE] 73.Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan. van den Broek I, Amsalu R, Balasegaram M, Hepple P, Alemu E, Hussein el B, Al-Faith M, Montgomery J, Checchi F. Malar J. 2005 Feb 24;4(1):14. PMID: 15730557 [PubMed - indexed for MEDLINE] 74.Antimalarial pharmacodynamics of chalcone derivatives in combination with artemisinin against Plasmodium falciparum in vitro. Bhattacharya A, Mishra LC, Sharma M, Awasthi SK, Bhasin VK. Eur J Med Chem. 2009 Sep;44(9):3388-93. doi: 10.1016/j.ejmech.2009.02.008. Epub 2009 Feb 21. PMID: 19269069 [PubMed - indexed for MEDLINE] 75. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ. Lancet. 2000 Jul 22;356(9226):297-302. PMID:11071185 [PubMed - indexed for MEDLINE] 76.Effects of artemisinin derivatives on malaria transmissibility. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ. Lancet. 1996 Jun 15;347(9016):1654-8. PMID: 8642959 [PubMed - indexed for MEDLINE] 77. Use of artemisinin derivatives for the control of malaria. Nosten F, Hien TT, White NJ. Med Trop (Mars). 1998;58(3 Suppl):45-9. Review. Erratum in: Med Trop (Mars) 1998;58(4):368. PMID: 10212897 [PubMed - indexed for MEDLINE] 78. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Tjitra E, Baker J, Suprianto S, Cheng Q, Anstey NM. Antimicrob Agents Chemother. 2002 Dec;46(12):3947-53. PMID: 12435700 [PubMed - indexed for MEDLINE] 79. Detection of artemisinin-resistant Plasmodium falciparum in malarial infection: a brief review of methods. Quashie NB. J Trop Pediatr. 2010 Apr;56(2):119-21. doi: 10.1093/tropej/fmp074. Epub 2009 Aug 5. Review. PMID: 19656841 [PubMed - indexed for MEDLINE] 80. [Evaluation of the quality of prescription and dispensing of artemisinin-based therapeutic combinations in the Bamako District, Mali]. Eve S, Samba D, Benoît D, Diawara SI, Seidina D, Saibou D, Karim T, Drissa K, Seydou D, Fanta Mady TS, Mahamadou D. Mali Med. 2010;25(3):31-40. French. PMID: 21441091 [PubMed - indexed for MEDLINE] 81. Mekong malaria. II. Update of malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia. Socheat D, Denis MB, Fandeur T, Zhang Z, Yang H, Xu J, Zhou X, Phompida S, Phetsouvanh R, Lwin S, Lin K, Win T, Than SW, Htut Y, Prajakwong S, Rojanawatsirivet C, Tipmontree R, Vijaykadga S, Konchom S, Cong le D, Thien NT, Thuan le K, Ringwald P, Schapira A, Christophel E, Palmer K, Arbani PR, Prasittisuk C, Rastogi R, Monti F, Urbani C, Tsuyuoka R, Hoyer S, Otega L, Thimasarn K, Songcharoen S, Meert JP, Gay F, Crissman L, Cho-Min-Naing, Chansuda W, Darasri D, Indaratna K, Singhasivanon P, Chuprapawan S, Looareesuwan S, Supavej S, Kidson C, Baimai V, Yimsamran S, Buchachart K. Southeast Asian J Trop Med Public Health. 2003;34 Suppl 4:1-102. PMID: 15906747 [PubMed - indexed for MEDLINE] 82.Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Bull World Health Organ. 1994;72(2):233-8. PMID: 8205643 [PubMed - indexed for MEDLINE] 83.[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine]. Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M. Sante. 2008 Jan-Mar;18(1):43-7. doi: 10.1684/san.2008.0103. French. PMID: 18684691 [PubMed - indexed for MEDLINE] 84.The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania. Njau JD, Goodman CA, Kachur SP, Mulligan J, Munkondya JS, McHomvu N, Abdulla S, Bloland P, Mills A. Malar J. 2008 Jan 7;7:4. doi: 10.1186/1475-2875-7-4. PMID: 18179716 [PubMed - indexed for MEDLINE] 85.Novel molecular targets for antimalarial chemotherapy. Jana S, Paliwal J. Int J Antimicrob Agents. 2007 Jul;30(1):4-10. Epub 2007 Mar 6. Review. PMID: 17339102 [PubMed - indexed for MEDLINE] 86. Treatment of falciparum malaria in the age of drug resistance. Shanks GD. J Postgrad Med. 2006 Oct-Dec;52(4):277-80. Review. PMID: 17102546 [PubMed - indexed for MEDLINE] 87. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii. Walker DJ, Pitsch JL, Peng MM, Robinson BL, Peters W, Bhisutthibhan J, Meshnick SR. Antimicrob Agents Chemother. 2000 Feb;44(2):344-7. PMID: 10639360 [PubMed - indexed for MEDLINE] 88. Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities. Whitty CJ, Chandler C, Ansah E, Leslie T, Staedke SG. Malar J. 2008 Dec 11;7 Suppl 1:S7. doi: 10.1186/1475-2875-7-S1-S7. Review. PMID: 19091041 [PubMed - indexed for MEDLINE] 89. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Barnes KI, Chanda P, Ab Barnabas G. Malar J. 2009 Oct 12;8 Suppl 1:S8. doi: 10.1186/1475-2875-8-S1-S8. Review. PMID: 19818175 [PubMed - indexed for MEDLINE] 90. Current perspectives on the mechanism of action of artemisinins. Golenser J, Waknine JH, Krugliak M, Hunt NH, Grau GE. Int J Parasitol. 2006 Dec;36(14):1427-41. Epub 2006 Sep 12. Review. PMID: 17005183[PubMed - indexed for MEDLINE] 91. Artemisinin-resistant malaria in the Asia-Pacific region. Tulloch J, David B, Newman RD, Meek S. Lancet. 2012 Oct 30. doi:pii: S0140-6736(12)61820-0. 10.1016/S0140-6736(12)61820-0. [Epub ahead of print] No abstract available. PMID: 23122219 [PubMed - as supplied by publisher] 92. Editorial: antimalarial drug discovery and design in the era of resistance. Bell A. Curr Pharm Des. 2013;19(2):264-5. No abstract available. PMID:22973889 [PubMed - in process] 94. Efficacy of Quinine, Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine as Rescue Treatment for Uncomplicated Malaria in Ugandan Children Adoke Yeka, James Tibenderana, Jane Achan, Umberto D'Alessandro, Ambrose O. Talisuna PLoS one. 2013; 8(1): e53772. Published online 2013 January 22. doi: 10.1371/journal.pone.0053772 PMCID: PMC3551967 Article PubReader PDF–285K Supplementary Material 95. Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border Fang Huang, Linhua Tang, Henglin Yang, Shuisen Zhou, Xiaodong Sun, Hui Liu Malar J. 2012; 11: 278. Published online 2012 August 16. doi: 10.1186/1475-2875-11-278 PMCID: PMC3492106 Article PubReader PDF–638K 96. Subacute Therapeutic Dosing of Artemether-Lumefantrine and Artesunate-Amodiaquine Combination Preserves Plasma Cholesterol, Renal Antioxidant Status, and Organ Weights in Rats Chiagoziem A. Otuechere, Gloria Edewor, Oluwafemi Ezekiel Kale, Martins Ekor Malar Res Treat. 2012; 2012: 257986. Published online 2012 July 10. doi: 10.1155/2012/257986 PMCID: PMC3400373 Article PubReader PDF–515K 97. Antimalarial Activity and Mechanisms of Action of Two Novel 4-Aminoquinolines against Chloroquine-Resistant Parasites Anna Caroline Campos Aguiar, Raquel de Meneses Santos, Flávio Júnior Barbosa Figueiredo, Wilian Augusto Cortopassi, André Silva Pimentel, Tanos Celmar Costa França, Mario Roberto Meneghetti, Antoniana Ursine Krettli PLoS one. 2012; 7(5): e37259. Published online 2012 May 23. doi: 10.1371/journal.pone.0037259 PMCID: PMC3359361 Article PubReader PDF–332K Supplementary Material 98. Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocol Justin Pulford, Ivo Mueller, Peter M Siba, Manuel W Hetzel Malar J. 2012; 11: 157. Published online 2012 May 7. doi: 10.1186/1475-2875-11-157 PMCID: PMC3441287 Article PubReader PDF–205K 99. MK-4815, a Potential New Oral Agent for Treatment of Malaria Mary Ann Powles, John Allocco, Lai Yeung, Bakela Nare, Paul Liberator, Dennis Schmatz Antimicrob Agents Chemother. 2012 May; 56(5): 2414–2419. doi: 10.1128/AAC.05326-11 PMCID: PMC3346645 Article PubReader PDF–408K 100. Synthesis of Artemiside and Its Effects in Combination with Conventional Drugs against Severe Murine Malaria Jin Guo, Armand W. Guiguemde, Annael Bentura-Marciano, Julie Clark, Richard K. Haynes, Wing-Chi Chan, Ho-Ning Wong, Nicholas H. Hunt, R. Kiplin Guy, Jacob Golenser Antimicrob Agents Chemother. 2012 January; 56(1): 163–173. doi: 10.1128/AAC.05006-11 PMCID: PMC3256061 Article PubReader PDF–3.5M 101. The Plasmodium falciparum Malaria M1 Alanyl Aminopeptidase (PfA-M1): Insights of Catalytic Mechanism and Function from MD Simulations Peter M. Jones, Mark W. Robinson, John P. Dalton, Anthony M. George PLoS one. 2011; 6(12): e28589. Published online 2011 December 21. doi: 10.1371/journal.pone.0028589 PMCID: PMC3244404 Article PubReader PDF–1.3M Supplementary Material 102. Cyclopropyl Carboxamides, a Chemically Novel Class of Antimalarial Agents Identified in a Phenotypic Screen Laura M. Sanz, M. Belen Jiménez-Díaz, Benigno Crespo, Cristina De-Cozar, M. Jesus Almela, Iñigo Angulo-Barturen, Pablo Castañeda, Javier Ibañez, Esther Pilar Fernández, Santiago Ferrer, Esperanza Herreros, Sonia Lozano, María Santos Martínez, Lourdes Rueda, Jeremy N. Burrows, Jose F. García-Bustos, Francisco-Javier Gamo Antimicrob Agents Chemother. 2011 December; 55(12): 5740–5745. doi: 10.1128/AAC.05188-11 PMCID: PMC3232824 Article PubReader PDF–705K 102. Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum Connor O’Brien, Philipp P. Henrich, Neha Passi, David A. Fidock Curr Opin Infect Dis. Author manuscript; available in PMC 2012 January 28. Published in final edited form as: Curr Opin Infect Dis. 2011 December; 24(6): 570–577. PMCID: PMC3268008 Article PubReader PDF–972K 104. Polymorphisms of Molecular Markers of Antimalarial Drug Resistance and Relationship with Artesunate-Mefloquine Combination Therapy in Patients with Uncomplicated Plasmodium falciparum Malaria in Thailand Poonuch Muhamad, Papichaya Phompradit, Wannapa Sornjai, Thunyaluk Maensathian, Wanna Chaijaroenkul, Ronnatrai Rueangweerayut, Kesara Na-Bangchang Am J Trop Med Hyg. 2011 September 1; 85(3): 568–572. doi: 10.4269/ajtmh.2011.11-0194 PMCID: PMC3163886 Article PubReader PDF–538K 105. Can pharmacogenomics improve malaria drug policy? Mary W Roederer, Howard McLeod, Jonathan J Juliano Bull World Health Organ. 2011 November 1; 89(11): 838–845. Published online 2011 September 1. doi: 10.2471/BLT.11.087320 PMCID: PMC3209725 Article PubReader PDF–1.4M
|
TRANG CHỦ
